Profit

India business robust in terms of growth: Glenmark on Q1 results

PUBLISHED ON: August 2, 2013 | Duration: 4 min, 33 sec

facebooktwitteremailkoo
loading..
Glenn Saldanha, chairman and managing director of Glenmark Pharma, tells NDTV Profit that the company's Indian business has been robust in terms of growth in the quarter ended June. Indicating why US business revenues have been flat, he also briefs us on Glenmark's current new chemical entity (NCE) entries in the pipeline.
ALSO WATCH
'7% से अधिक GDP विकास दर संभव' - 2022-23 को लेकर बोले RBI गवर्नर शक्तिकांत दास

Related Videos

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com